Immature NK cells, capable of producing IL-22, are present in human uterine mucosa.
NK cells are the dominant population of immune cells in the endometrium in the secretory phase of the menstrual cycle and in the decidua in early pregnancy. The possibility that this is a site of NK cell development is of particular interest because of the cyclical death and regeneration of the NK population during the menstrual cycle. To investigate this, we searched for NK developmental stages 1-4, based on expression of CD34, CD117, and CD94. In this study, we report that a heterogeneous population of stage 3 NK precursor (CD34(-)CD117(+)CD94(-)) and mature stage 4 NK (CD34(-)CD117(-/+)CD94(+)) cells, but not multipotent stages 1 and 2 (CD34(+)), are present in the uterine mucosa. Cells within the uterine stage 3 population are able to give rise to mature stage 4-like cells in vitro but also produce IL-22 and express RORC and LTA. We also found stage 3 cells with NK progenitor potential in peripheral blood. We propose that stage 3 cells are recruited from the blood to the uterus and mature in the uterine microenvironment to become distinctive uterine NK cells. IL-22 producers in this population might have a physiological role in this specialist mucosa dedicated to reproduction.
Male
Victoria
V
Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
Hughes
Tiffany
T
McClory
Susan
S
Colucci
Francesco
F
Caligiuri
Michael A
MA
Moffett
Ashley
A
D002454:Cell Differentiation / Q000276:immunology; D002469:Cell Separation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology*; D007150:Immunohistochemistry; D007378:Interleukins / Q000276:immunology / Q000378:metabolism; D007694:Killer Cells, Natural / Q000166:cytology* / Q000276:immunology*; D009092:Mucous Membrane / Q000166:cytology / Q000276:immunology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014599:Uterus / Q000166:cytology / Q000276:immunology*; D000097043:Interleukin-22
D007378:Interleukins; D000097043:Interleukin-22
Immunity. 2010 Jun 25;32(6):803-14
20620944
J Immunol. 2002 Jan 1;168(1):22-8
11751942
Blood. 2006 Dec 1;108(12):3824-33
16902150
Biol Reprod. 2000 Apr;62(4):959-68
10727265
J Immunol. 2008 Nov 1;181(9):6140-7
18941204
J Exp Med. 2006 Apr 17;203(4):1033-43
16606675
Trends Immunol. 2001 Nov;22(11):633-40
11698225
Nature. 2009 Feb 5;457(7230):722-5
18978771
J Immunol. 2009 Aug 1;183(3):1789-96
19587011
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3378-83
17360654
J Leukoc Biol. 2006 Sep;80(3):572-80
16816146
J Immunol. 2007 Apr 15;178(8):4947-55
17404276
Blood. 1992 Nov 1;80(9):2182-7
1384796
J Immunol. 1979 Oct;123(4):1832-8
383842
Eur J Immunol. 1997 Apr;27(4):979-83
9130653
J Immunol. 1977 Apr;118(4):1503-6
300411
Biol Reprod. 2006 Jan;74(1):35-40
16148216
Hum Reprod. 1993 Dec;8(12):2061-7
7512092
Nat Immunol. 2006 Nov;7(11):1217-24
17013389
Hum Reprod. 2005 Jun;20(6):1477-84
15734760
Immunol Rev. 2006 Dec;214:56-72
17100876
Blood. 2008 Mar 15;111(6):3108-15
18187664
J Exp Med. 2010 Feb 15;207(2):281-90
20142432
J Anat. 1984 Dec;139 ( Pt 4):593-8
6396290
Hum Immunol. 1989 Mar;24(3):195-205
2925453
Eur J Immunol. 2001 Jun;31(6):1900-9
11433387
Blood. 2009 Apr 23;113(17):4008-10
19244159
Hum Reprod. 2007 Apr;22(4):919-26
17208945
J Immunol. 2008 Jul 1;181(1):39-46
18566368
Methods Mol Biol. 2010;612:447-63
20033659
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10961-6
20534450
Blood. 1994 May 1;83(9):2594-601
7513206
Dev Immunol. 1991;1(3):169-90
1726555
J Exp Med. 2003 Oct 20;198(8):1201-12
14568979
Immunity. 2005 Mar;22(3):295-304
15780987
J Immunol. 2004 Dec 1;173(11):6760-6
15557169
Cell Tissue Res. 1983;233(3):647-56
6627353
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5795-800
19297623
Nat Med. 2006 Sep;12(9):1065-74
16892062
Immunobiology. 2004;209(7):569-74
15568621
Immunity. 2008 Dec 19;29(6):958-70
19084435
Nat Immunol. 2009 Jan;10(1):66-74
19029905
Cytokine. 1994 Mar;6(2):195-205
7518262
Annu Rev Immunol. 2006;24:257-86
16551250